Insiders Invivyd, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-08 EDT			5-day change	1st Jan Change
2.53 ^USD	+0.80%		+13.96%	-35.79%

05-07	Invivyd, Inc. to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback	CI
04-15	Invivyd, Inc. Receives Healthcare Common Procedure Coding System Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services Covering Pemgarda	CI

Invivyd Names Jeremy Gowler as Interim CEO	04-12	MT
Invivyd, Inc. Announces Executive Changes	04-12	CI
Invivyd, Inc. Announces CEO Changes	04-12	CI
Invivyd Names William Duke as Finance Chief	23-09-05	MT
Invivyd, Inc. Appoints William Duke as Chief Financial Officer	23-09-05	CI
Invivyd, Inc. Appoints Sara Cotter to Board of Directors	23-07-28	CI
Invivyd Appoints Robert Allen as Chief Scientific Officer and Stacy Price as Chief Technology and Manufacturing Officer	23-04-12	CI
Invivyd, Inc. Announces Executive Changes	23-02-03	CI
Invivyd Names Jeremy Gowler as Chief Operating, Commercial Officer	22-12-07	MT
Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical Officer	22-12-06	CI
Invivyd Announces Board Changes	22-10-24	CI
Invivyd Eliminates Certain Job Positions in 'Resource Realignment' -- Shares up After Hours	22-10-13	MT
Invivyd, Inc. Announces Executive Changes	22-10-13	CI
Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer	22-10-13	CI
Adagio Therapeutics, Inc. has Changed its Name to Invivyd, Inc	22-09-13	CI
Insider Buy: Adagio Therapeutics	22-08-19	MT
Adagio Therapeutics Appoints David Hering Permanent CEO and Director	22-07-05	MT
Adagio Announces David Hering Named Permanent Chief Executive Officer and Director	22-07-05	GL
Adagio Therapeutics, Inc. Appoints David Hering as Director	22-07-05	CI
Adagio Therapeutics, Inc. Appoints David Hering Permanent Chief Executive Officer	22-07-05	CI

No results for this search